People
Renowned drug discovery leader to guide alliance formed to improve scientific exchange in UK drug discovery community
Valeritas and its subsidiaries filed for Chapter 11 bankruptcy on February 9, 2020 in the District of Delaware. At the same time, Zealand entered into the definitive deal to buy the assets.
There’s a growing demand for life sciences professionals in Massachusetts, but a new report indicates that the home-grown talent pipeline is not adequate enough to meet the growing demands in the Bay State.
It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.
This morning, San Diego-based Illumina, Inc. announced that Gottlieb joined its board of directors effective Feb. 4.
Pharma and biotech companies strengthen their leadership teams and boards with this weeks appointments.
One day after GlaxoSmithKline began to outline some of the broad strokes of splitting the company into two separate entities, more details are coming into place – particularly staffing concerns over the integration of the company’s vaccine business into its pharma operations.
Findacure co-founder will apply extensive drug repurposing and rare disease expertise to progress Healx’s drug candidates into the clinic.
Chants of “H.R. 3” broke out in the House of Representatives chamber during Tuesday night’s State of the Union Address as Democratic lawmakers urged action on the bill passed late last year that could impact the price of prescription medications paid for by government-funded health programs.
BryoLogyx Inc., announced that David Crockford has joined the Company as vice president of clinical development and logistics, a new position.
PRESS RELEASES